Puerto Rico’s tax cuts to “hinder” offshore biopharma firms
PhRMA says a new Puerto Rico law to tax offshore manufacturers will “dramatically hinder” biopharma companies.
Archives for October 26, 2010
Biocon investing $161m in Malaysian biomanufacturing site
India-based Biocon is investing RM500m ($161m) in Malaysia to establish a cGMP biomanufacturing and R&D facility.
Lonza boosts capacity use but tough regulators add volatility
Lonza is seeing increased capacity utilisation and project pipelines in custom manufacturing but warned more stringent regulatory approval is creating volatility.